• ქართული
  • English
  • Pharma firm Gilead to raise Galapagos stake in $5.1 billion deal

    Gilead Sciences Inc will invest $5.1 billion to increase its stake in Galapagos NV and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the companies said on Sunday.

    Market Quotes by TradingView